Literature DB >> 17205214

Serum hyaluronan levels in patients with knee osteoarthritis.

Yasemin Turan1, Serpil Bal, Alev Gurgan, Hatice Topac, Mehmet Koseoglu.   

Abstract

We examined the association between clinical parameters of disease activity and serum hyaluronic acid (HA) level in patients with knee osteoarthritis (OA). Fifty-eight patients with knee OA and 40 healthy individuals were included in this study. Demographic data were noted. The radiological evaluation was done according to Kellgren/Lawrence Grading System. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was used in evaluating the clinical disability caused by OA. Erythrocyte sedimentation rate (ESR) and serum C-reactive protein (CRP) level were determined in laboratory evaluations. Serum HA levels (in nanogram per milliliter) of both groups were measured by enzyme-linked immunosorbent assay. The mean ages of patients in OA group and control group were 57.58 (9.55) and 43.3(10.2) years, respectively. There was a significant difference between HA levels of both groups (p=0.02). Also, there was a significant correlation between HA level and disease duration (p=0.04), ESR (p=0.001), and CRP level (p<0.001). However, there was no significant correlation between HA levels with WOMAC and radiological grade (p>0.05). There is no satisfactory amount of data regarding HA level in OA. In our study, we demonstrated that HA was in high levels in the serum of patients with OA. We suggest that serum HA levels may be used as a marker to determine the disease activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17205214     DOI: 10.1007/s10067-006-0499-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  27 in total

Review 1.  Criteria for classification of clinical osteoarthritis.

Authors:  R D Altman
Journal:  J Rheumatol Suppl       Date:  1991-02

2.  Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid.

Authors:  J Faber; K Hørslev-Petersen; H Perrild; I Lorenzen
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

3.  Knee adduction moment, serum hyaluronan level, and disease severity in medial tibiofemoral osteoarthritis.

Authors:  L Sharma; D E Hurwitz; E J Thonar; J A Sum; M E Lenz; D D Dunlop; T J Schnitzer; G Kirwan-Mellis; T P Andriacchi
Journal:  Arthritis Rheum       Date:  1998-07

4.  C-reactive protein as a biomarker of emergent osteoarthritis.

Authors:  MaryFran Sowers; Mary Jannausch; Evan Stein; David Jamadar; Marc Hochberg; Laurie Lachance
Journal:  Osteoarthritis Cartilage       Date:  2002-08       Impact factor: 6.576

5.  Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis.

Authors:  R L Goldberg; J P Huff; M E Lenz; P Glickman; R Katz; E J Thonar
Journal:  Arthritis Rheum       Date:  1991-07

6.  Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine, or azathioprine.

Authors:  K Hørslev-Petersen; K D Bentsen; A Engström-Laurent; P Junker; P Halberg; I Lorenzen
Journal:  Ann Rheum Dis       Date:  1988-02       Impact factor: 19.103

7.  Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity.

Authors:  W Emlen; J Niebur; G Flanders; J Rutledge
Journal:  J Rheumatol       Date:  1996-06       Impact factor: 4.666

8.  Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project.

Authors:  Alan L Elliott; Virginia B Kraus; Gheorghe Luta; Thomas Stabler; Jordan B Renner; Janice Woodard; Anca D Dragomir; Charles G Helmick; Marc C Hochberg; Joanne M Jordan
Journal:  Arthritis Rheum       Date:  2005-01

9.  Relationship between plasma levels of hyaluronic acid and amyloid-associated osteoarthropathy in chronic hemodialysis patients.

Authors:  H Ozasa; K Chichibu; Y Tanaka; T Kondo; K Kitajima; K Ota
Journal:  Nephron       Date:  1992       Impact factor: 2.847

10.  Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uremia.

Authors:  R Hällgren; A Engström-Laurent; U Nisbeth
Journal:  Nephron       Date:  1987       Impact factor: 2.847

View more
  11 in total

1.  Serum hyaluronan levels increase with the total number of osteoarthritic joints and are strongly associated with the presence of knee and finger osteoarthritis.

Authors:  Eiji Sasaki; Eiichi Tsuda; Yuji Yamamoto; Koei Iwasaki; Ryo Inoue; Ippei Takahashi; Kaori Sawada; Hiroshi Fujita; Takashi Umeda; Shigeyuki Nakaji; Yasuyuki Ishibashi
Journal:  Int Orthop       Date:  2013-03-19       Impact factor: 3.075

2.  Biomarkers of incident radiographic knee osteoarthritis: do they vary by chronic knee symptoms?

Authors:  Yvonne M Golightly; Stephen W Marshall; Virginia B Kraus; Jordan B Renner; Andrés Villaveces; Carri Casteel; Joanne M Jordan
Journal:  Arthritis Rheum       Date:  2011-08

3.  Role of hyaluronic Acid in early diagnosis of knee osteoarthritis.

Authors:  Sudhir Singh; Dharmendra Kumar; Nishant Raj Sharma
Journal:  J Clin Diagn Res       Date:  2014-12-05

4.  Serum hyaluronic acid levels in patients with ankylosing spondylitis.

Authors:  Mehmet Tuncay Duruöz; Yasemin Turan; Lale Cerrahoglu; Banu Isbilen
Journal:  Clin Rheumatol       Date:  2007-10-23       Impact factor: 2.980

5.  In vitro and ex vivo effect of hyaluronic acid on erythrocyte flow properties.

Authors:  A Luquita; L Urli; M J Svetaz; A M Gennaro; M E Giorgetti; G Pistone; R Volpintesta; S Palatnik; M Rasia
Journal:  J Biomed Sci       Date:  2010-02-12       Impact factor: 8.410

6.  Evaluation of a quantitative measurement of suprapatellar effusion by ultrasonography and its association with symptoms of radiographic knee osteoarthritis: a cross-sectional observational study.

Authors:  Daisuke Chiba; Eiichi Tsuda; Shugo Maeda; Eiji Sasaki; Ippei Takahashi; Shigeyuki Nakaji; Yasuyuki Ishibashi
Journal:  Arthritis Res Ther       Date:  2016-08-04       Impact factor: 5.156

7.  Genetic markers of osteoarthritis: early diagnosis in susceptible Pakistani population.

Authors:  Yasmin Badshah; Maria Shabbir; Hunza Hayat; Zoha Fatima; Asad Burki; Sidra Khan; Shafiq Ur Rehman
Journal:  J Orthop Surg Res       Date:  2021-02-09       Impact factor: 2.359

8.  Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain.

Authors:  Beniamino Palmieri; Valentina Rottigni; Tommaso Iannitti
Journal:  Drug Des Devel Ther       Date:  2013-01-07       Impact factor: 4.162

9.  Serum hyaluronic acid concentration predicts the progression of joint space narrowing in normal knees and established knee osteoarthritis - a five-year prospective cohort study.

Authors:  Eiji Sasaki; Eiichi Tsuda; Yuji Yamamoto; Shugo Maeda; Ryo Inoue; Daisuke Chiba; Hiroshi Fujita; Ippei Takahashi; Takashi Umeda; Shigeyuki Nakaji; Yasuyuki Ishibashi
Journal:  Arthritis Res Ther       Date:  2015-10-10       Impact factor: 5.156

10.  Synovial fluid pretreatment with hyaluronidase facilitates isolation of CD44+ extracellular vesicles.

Authors:  Janneke Boere; Chris H A van de Lest; Sten F W M Libregts; Ger J A Arkesteijn; Willie J C Geerts; Esther N M Nolte-'t Hoen; Jos Malda; P René van Weeren; Marca H M Wauben
Journal:  J Extracell Vesicles       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.